See also this year's filing and all EDGAR filings for this company.
PDF Report 0000794172_2022_MERIDIAN_BIOSCIENCE_INC.pdf
Logs
info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Assets', 'missing_ratio': 0.3221187688699367, 'aggregate_val': 449722000, 'exp_sum': 663423000, 'exp_to_value': {'AssetsCurrent': 192807000, 'AssetsNoncurrent': 213701000, 'PropertyPlantAndEquipmentNet': 43214000, 'Goodwill': 198819000, 'remainder_Assets': 14882000}} |
info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Liabilities', 'missing_ratio': 0.008614002857726066, 'aggregate_val': 121420000, 'exp_sum': 122475000, 'exp_to_value': {'LiabilitiesNoncurrent': 74263000, 'LiabilitiesCurrent': 48212000, 'remainder_Liabilities': 0}} |
info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000794172, MERIDIAN BIOSCIENCE INC
xvar | xval | |
---|---|---|
0 | LiabilitiesNoncurrent | 74,263,000 |
1 | LiabilitiesCurrent | 48,212,000 |
2 | remainder_Liabilities | -1,055,000 |
3 | AssetsCurrent | 192,807,000 |
4 | AssetsNoncurrent | 213,701,000 |
5 | PropertyPlantAndEquipmentNet | 43,214,000 |
6 | Goodwill | 198,819,000 |
7 | remainder_Assets | -198,819,000 |
8 | GeneralAndAdministrativeExpense | 193,069,000 |
9 | ResearchAndDevelopmentExpense | 23,911,000 |
10 | remainder_Expenses | 26,926,000 |
11 | remainder_Revenues | 317,896,000 |
12 | remainder_NetIncome | -2,583,000 |
13 | remainder_ComprehensiveNetIncome | 2,058,000 |
yvar | yval | |
---|---|---|
0 | Liabilities | 121,420,000 |
1 | Assets | 449,722,000 |
2 | Expenses | 243,906,000 |
3 | Revenues | 317,896,000 |
4 | StockholdersEquity | 328,302,000 |
5 | NetIncome | 71,407,000 |
6 | ComprehensiveNetIncome | 72,436,000 |
7 | BaseVar | 568,792,500 |
8 | EconomicCapitalRatio | 1.23 |